FORESEE PHARMACEUTICALS USA INC has a total of 15 patent applications. Its first patent ever was published in 2019. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are HANGZHOU INNOGATE PHARMA CO LTD, SHANGHAI HAIHE PHARMACEUTICAL CO LTD and MIRATI THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | Singapore | 2 | |
#6 | Taiwan | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Liu Suying | 14 |
#2 | Yang Wenjin | 14 |
#3 | Chang Kai-Wei | 12 |
#4 | Tsai Cheng-Han | 12 |
#5 | Tsai Cheng Han | 2 |
#6 | Chang Kai Wei | 2 |
#7 | Kai-Wei Chang | 1 |
#8 | Wenjin Yang | 1 |
#9 | Cheng-Han Tsai | 1 |
#10 | Suying Liu | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019222154A1 | Matrix metalloproteinase (mmp) inhibitors and methods of use thereof |